R.D. Hofheinz

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

R.D. Hofheinz, Volker Heinemann, Ludwig Fischer von Weikersthal et al. · British Journal of Cancer · 2012 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial

R.D. Hofheinz, Dirk Arnold, Emmanouil Fokas et al. · Annals of Oncology · 2018 · 32 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial

T.O. Götze, Nils Homann, Harald Schmalenberg et al. · Zeitschrift für Gastroenterologie · 2017 · 26 citations

Medicine, Oncology, Perioperative Medicine +13

PG 6.2 Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis

Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price et al. · European Journal of Cancer · 2014 · 20 citations

Medicine, Oncology, Surgery +17

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses

Hans‐Joachim Schmoll, Alexander Stein, R.D. Hofheinz et al. · Annals of Oncology · 2016 · 14 citations

Medicine, Oncology, Surgery +16